Ovarian hyperstimulation syndrome: pathophysiology and prevention
- 6 February 2010
- journal article
- review article
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 27 (2-3), 121-128
- https://doi.org/10.1007/s10815-010-9387-6
Abstract
To review and discuss the pathophysiology and prevention strategies for ovarian hyperstimulation syndrome (OHSS), which is a condition that may occur in up to 20% of the high risk women submitted to assisted reproductive technology cycles.Keywords
This publication has 51 references indexed in Scilit:
- Does coasting, a procedure to avoid ovarian hyperstimulation syndrome, affect assisted reproduction cycle outcome?Fertility and Sterility, 2010
- Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coastingFertility and Sterility, 2009
- Coasting vs. cryopreservation of all embryos for prevention of ovarian hyperstimulation syndrome in in vitro fertilizationFertility and Sterility, 2008
- A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cyclesHuman Reproduction, 2008
- Human albumin does not prevent ovarian hyperstimulation syndrome in assisted reproductive technology program: a prospective randomized placebo-controlled double blind studyFertility and Sterility, 2007
- The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled studyFertility and Sterility, 2007
- Developmental potential of in vitro– and in vivo–matured human oocytes collected from stimulated and unstimulated ovariesFertility and Sterility, 2006
- The optimal length of ‘coasting protocol’ in women at risk of ovarian hyperstimulation syndrome undergoingin vitrofertilizationHuman Fertility, 2006
- Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndromePublished by Wiley ,2002
- Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndromeThe Lancet, 1994